Autologous dendritic cell therapy/Dengue virus adjuvant
N/A
Report date: 2025/09/12 20:01:19
Base Information
Drug NameAutologous dendritic cell therapy/Dengue virus adjuvant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrimevax Immuno-Oncology Inc
China Registration ClassN/A
Develop Information
Active CompaniesPrimevax Immuno-Oncology Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A